Heavy blow for Covid Vaccine Stocks with a loss of 3.5%. Novavax tumbles, Onco Sec bounces.

Really hard punch in the gut for COVID VACCINE STOCKS. 

On a day when the worst performer in 2021 (OncoSec) gains almost 14% and Novavax falls just under 14%, the overall hit was a 3.5%. There were 24 stocks that dropped with only three gaining grounds.

Adaptive slipped just under 9% and BioNTech tumbled 8%.